{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:55:31Z","timestamp":1791550531105,"version":"4.3.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/ajg.2012.406","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T10:41:04Z","timestamp":1357641664000},"page":"240-248","source":"Crossref","is-referenced-by-count":184,"title":["Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease"],"prefix":"10.14309","volume":"108","author":[{"given":"Millie D","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Kappelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210210","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1053\/j.gastro.2007.09.022","article-title":"Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.","volume":"133","author":"Hutfless","year":"2007","journal-title":"Gastroenterology"},{"key":"R2-19-20210210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/MLR.0b013e3181f38006","article-title":"Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005.","volume":"48","author":"Ruhnke","year":"2010","journal-title":"Med Care"},{"key":"R3-19-20210210","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States.","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"R4-19-20210210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohns disease: the Mayo clinic experience in 500 patients.","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"R5-19-20210210","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R6-19-20210210","first-page":"1832","article-title":"Acute lower respiratory tract infections in patients with rheumatoid arthritis.","volume":"34","author":"Coyne","year":"2007","journal-title":"J Rheumatol"},{"key":"R7-19-20210210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","article-title":"The risk of infections with biologic therapies for rheumatoid arthritis.","volume":"39","author":"Furst","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"R8-19-20210210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MD.0b013e318211106a","article-title":"TNF-alpha antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis.","volume":"90","author":"Lane","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"R9-19-20210210","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.","volume":"306","author":"Grijalva","year":"2011","journal-title":"JAMA"},{"key":"R10-19-20210210","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R11-19-20210210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","article-title":"Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.","volume":"8","author":"Long","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-19-20210210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cgh.2008.10.007","article-title":"Suboptimal rates of cervical testing among women with inflammatory bowel disease.","volume":"7","author":"Long","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R13-19-20210210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/rmed.2000.1027","article-title":"Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.","volume":"95","author":"Stempel","year":"2001","journal-title":"Respir Med"},{"key":"R14-19-20210210","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","article-title":"Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-19-20210210","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohns disease and ulcerative colitis in the United States.","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R16-19-20210210","first-page":"1299","article-title":"Diagnosis and management of community-acquired pneumonia in adults.","volume":"83","author":"Watkins","year":"2011","journal-title":"Am Fam Physician"},{"key":"R17-19-20210210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2006.02.022","article-title":"Disease, temporal and sociodemographic influences on initial treatment of community-acquired pneumonia in Manitoba, Canada.","volume":"28","author":"Carrie","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"R18-19-20210210","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ibd.21348","article-title":"Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.","volume":"17","author":"Lund","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R19-19-20210210","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"R20-19-20210210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R21-19-20210210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/dc09-0880","article-title":"Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.","volume":"33","author":"Ehrlich","year":"2010","journal-title":"Diabetes Care"},{"key":"R22-19-20210210","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death.","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"R23-19-20210210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","article-title":"Guidelines for immunizations in patients with inflammatory bowel disease.","volume":"10","author":"Sands","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"R25-19-20210210","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1053\/j.gastro.2003.09.029","article-title":"Mortality in inflammatory bowel disease: a population-based cohort study.","volume":"125","author":"Card","year":"2003","journal-title":"Gastroenterology"},{"key":"R26-19-20210210","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2036.2010.04284.x","article-title":"Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.","volume":"31","author":"Johnstone","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R27-19-20210210","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","article-title":"Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.","volume":"6","author":"Roy","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"key":"R28-19-20210210","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1532-5415.2011.03586.x","article-title":"Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study.","volume":"59","author":"Dublin","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"R29-19-20210210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohns disease: TREAT registry.","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-19-20210210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ibd.20021","article-title":"Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.","volume":"13","author":"Herrinton","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R31-19-20210210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1062860605280358","article-title":"Accuracy of administrative data for identifying patients with pneumonia.","volume":"20","author":"Aronsky","year":"2005","journal-title":"Am J Med Qual"},{"key":"R32-19-20210210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.","volume":"15","author":"Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R33-19-20210210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1378\/chest.116.2.375","article-title":"Proportion of community-acquired pneumonia cases attributable to tobacco smoking.","volume":"116","author":"Almirall","year":"1999","journal-title":"Chest"},{"key":"R34-19-20210210","first-page":"1305","article-title":"States, 2004-2010.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R35-19-20210210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology.","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2012406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2012406","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2012406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201302000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:44:56Z","timestamp":1786542296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201302000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2012.406","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}